NEXTBio Capital Management LP
Top Portfolio Positions
24 positions ·
$215,369,990 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
604,534 | $31,871,032 | 14.80% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
229,619 | $24,201,842 | 11.24% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
3,149,907 | $20,253,902 | 9.40% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
999,967 | $17,839,411 | 8.28% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
2,021,407 | $11,178,380 | 5.19% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
126,078 | $10,965,003 | 5.09% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
183,225 | $10,654,533 | 4.95% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
82,686 | $10,306,809 | 4.79% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
426,736 | $8,342,688 | 3.87% | |
| IVA |
Inventiva S.A.
Healthcare
|
1,333,484 | $7,400,836 | 3.44% |
Portfolio Trend
2 quarters · across all stocks
Holdings in CBIO
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,849,364 | 372,856 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,422,072 | 372,856 | Shares | Sole | 2026-02-13 | |
| No 13F history on record for this holder in this stock. | ||||||